Diagnosis of ischemia in hypertrophic cardiomyopathy: Role of computed tomography and nuclear stress testing

5Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In lowâ€"intermediate-risk symptomatic patients with HCM, both NST and CCTA are acceptable diagnostic tools for the evaluation of myocardial ischemia. In the presence of nuclear perfusion defect, CCTA can be used to rule out significant epicardial stenosis. Presence of significant major epicardial artery stenosis on CCTA or high-risk patients could be considered for invasive angiography.

Cite

CITATION STYLE

APA

Chaikriangkraia, K., Chebrolua, L., Bhatti, S., & Chang, S. M. (2015, August 24). Diagnosis of ischemia in hypertrophic cardiomyopathy: Role of computed tomography and nuclear stress testing. Current Opinion in Cardiology. Lippincott Williams and Wilkins. https://doi.org/10.1097/HCO.0000000000000201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free